Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma.
D000380:Agranulocytosis / Q000150:complications; D001428:Bacterial Vaccines / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000382:microbiology; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D003428:Cross Infection / Q000382:microbiology; D004359:Drug Therapy, Combination; D004926:Escherichia coli / Q000187:drug effects; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007709:Klebsiella / Q000302:isolation & purification; D007938:Leukemia / Q000150:complications / Q000382:microbiology*; D007945:Leukemia, Lymphoid / Q000150:complications; D008223:Lymphoma / Q000150:complications / Q000382:microbiology*; D011511:Proteus / Q000302:isolation & purification; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000209:etiology*; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification*; D018805:Sepsis / Q000209:etiology
D001428:Bacterial Vaccines; D005839:Gentamicins; D002228:Carbenicillin; D002512:Cephalothin